mhurhangee/patent-ind-claim-en huggingface dataset:
A battery terminal manufacturing system comprising: a tool assembly including: a base; a first forming member movably coupled to the base and having at least a first curved protrusion extending therefrom; a second forming member movably coupled to the base and having at least a second curved protrusion extending therefrom; and a part support fixedly attached to the base and positioned between the first and second forming members; and an unfinished battery terminal removably positioned on the part support, wherein the battery terminal includes at least one annular bifurcated acid ring protruding from an exterior surface thereof and having a first lip spaced apart from a second lip, wherein the first and second forming members move toward each other to receive the battery terminal between the first and second forming members, whereby the first and second protrusions are driven against the unfinished battery terminal between the first and second lips to compress and flare the first and second lips away from each other. a tool assembly including: a base; a first forming member movably coupled to the base and having at least a first curved protrusion extending therefrom; a second forming member movably coupled to the base and having at least a second curved protrusion extending therefrom; and a part support fixedly attached to the base and positioned between the first and second forming members; and a base; a first forming member movably coupled to the base and having at least a first curved protrusion extending therefrom; a second forming member movably coupled to the base and having at least a second curved protrusion extending therefrom; and a part support fixedly attached to the base and positioned between the first and second forming members; and an unfinished battery terminal removably positioned on the part support, wherein the battery terminal includes at least one annular bifurcated acid ring protruding from an exterior surface thereof and having a first lip spaced apart from a second lip, wherein the first and second forming members move toward each other to receive the battery terminal between the first and second forming members, whereby the first and second protrusions are driven against the unfinished battery terminal between the first and second lips to compress and flare the first and second lips away from each other.
A slideway lubricant composition including a major amount of a base lubricating oil; a phosphorus containing friction modifier providing 0.01 to 1 weight percent of a hydrocarbyl phosphonate monoester to the slideway lubricant composition; the hydrocarbyl phosphonate monoester including a C1 to C4 alkyl group in the monoester moiety and 12 to 30 carbon atoms in the hydrocarbyl moiety; further comprising at least one of a) a thiophosphate ester having the formula wherein R 6 is a C1 to C10 linear or branched carboxylic group or a C1 to C10 linear or branched alkyl alkanoate group and each R 7 is independently a linear or branched C1 to C10 hydrocarbyl group; an b) saturated, monounsaturated, or polyunsaturated C12 to C30 fatty acids or fatty acid esters. a major amount of a base lubricating oil; a phosphorus containing friction modifier providing 0.01 to 1 weight percent of a hydrocarbyl phosphonate monoester to the slideway lubricant composition; the hydrocarbyl phosphonate monoester including a C1 to C4 alkyl group in the monoester moiety and 12 to 30 carbon atoms in the hydrocarbyl moiety; further comprising at least one of a) a thiophosphate ester having the formula wherein R 6 is a C1 to C10 linear or branched carboxylic group or a C1 to C10 linear or branched alkyl alkanoate group and each R 7 is independently a linear or branched C1 to C10 hydrocarbyl group; an b) saturated, monounsaturated, or polyunsaturated C12 to C30 fatty acids or fatty acid esters. a) a thiophosphate ester having the formula wherein R 6 is a C1 to C10 linear or branched carboxylic group or a C1 to C10 linear or branched alkyl alkanoate group and each R 7 is independently a linear or branched C1 to C10 hydrocarbyl group; an b) saturated, monounsaturated, or polyunsaturated C12 to C30 fatty acids or fatty acid esters.
A computer implemented method for power management of a wearable device or an implantable device comprising a plurality of sensors , each sensor configured for providing a corresponding physiological information of a user, each sensor being further configured to be operated in at least two power modes comprising a first power mode and a second power mode, wherein in the first power mode the physiological information of the user is gathered and in the second power mode the sensor consumes less power than in the first power mode, the method comprising: - receiving a signal being indicative of whether a health device which is configured to treat a health condition of the user is in use, wherein the health device is positioned at a different location with respect to the user than the wearable device or the implantable device, wherein the signal further comprises information about a type of the health device in use; - selecting at least one sensor from the plurality of the sensors of the wearable device based on the type of the health device in use; - operating the selected at least one sensor in the first power mode for a time duration and operating the selected at least one sensor in second power mode thereafter. - receiving a signal being indicative of whether a health device which is configured to treat a health condition of the user is in use, wherein the health device is positioned at a different location with respect to the user than the wearable device or the implantable device, wherein the signal further comprises information about a type of the health device in use; - selecting at least one sensor from the plurality of the sensors of the wearable device based on the type of the health device in use; - operating the selected at least one sensor in the first power mode for a time duration and operating the selected at least one sensor in second power mode thereafter.
A method for producing documents, wherein a paper web is removed from a paper reel , said paper web is conveyed continuously, is printed using a rotary printing machine and is subsequently separated into at least two partial webs , wherein at least one first partial web (4.1) is displaced in the transverse direction and is assigned to a second partial web (4.2) lying thereabove or therebelow in such a manner that in each case a section of the first partial web together with a section of the second partial web form at least two sheets of the document that are subsequently cut to size, are folded longitudinally or transversely approximately centrally, are connected to one another and can be folded to form a document having at least eight pages, wherein at least one page of the document of the first partial web (4.1) is coated at least selectively with adhesive within the region of the fold of the document and is additionally coated in at least one region outside the fold and is adhesively bonded to at least one facing page of the document of the second partial web (4.2) to form a thickened page of the document, wherein the thickened page of the document has a thickness which is at least twice the size of the thickness of a non-adhesively-bonded page, wherein the adhesive is applied distributed over the entire surface of the page of the document of the first partial web (4.1), or wherein the page of the document of the first partial web (4.1) and the facing page of the document of the second partial web (4.2) are adhesively bonded to each other in the region of the outer edge in such a manner that the two facing pages form a pocket therebetween, or wherein individual surface regions of a page to be adhesively bonded are not coated with adhesive , and the opposite page is designed in the manner of an advent calendar with perforated window sections which can be opened manually.
An IL13Rα2-specific chimeric antigen receptor (CAR) comprising: (A) an ectodomain comprising each of the amino acid sequences of: (i) NYLMN (SEQ ID NO: 1); (ii) RIDPYDGDIDYNQNFKD (SEQ ID NO: 2); (III) GYGTAYGVDY (SEQ ID NO: 3); (iv) RASESVDNYGISFMN (SEQ ID NO: 4); (v) AASRQGSG (SEQ ID NO: 5); and (vi) QQSKEVPWT (SEQ ID NO: 6); (B) a spacer region; (C) a transmembrane domain; and (D) an endodomain selected from the group consisting of CD3.ζ, CD28.ζ, CD28.OX40.ζ, CD28.41BB.ζ and 41BB.ζ. (A) an ectodomain comprising each of the amino acid sequences of: (i) NYLMN (SEQ ID NO: 1); (ii) RIDPYDGDIDYNQNFKD (SEQ ID NO: 2); (III) GYGTAYGVDY (SEQ ID NO: 3); (iv) RASESVDNYGISFMN (SEQ ID NO: 4); (v) AASRQGSG (SEQ ID NO: 5); and (vi) QQSKEVPWT (SEQ ID NO: 6); (i) NYLMN (SEQ ID NO: 1); (ii) RIDPYDGDIDYNQNFKD (SEQ ID NO: 2); (III) GYGTAYGVDY (SEQ ID NO: 3); (iv) RASESVDNYGISFMN (SEQ ID NO: 4); (v) AASRQGSG (SEQ ID NO: 5); and (vi) QQSKEVPWT (SEQ ID NO: 6); (B) a spacer region; (C) a transmembrane domain; and (D) an endodomain selected from the group consisting of CD3.ζ, CD28.ζ, CD28.OX40.ζ, CD28.41BB.ζ and 41BB.ζ.
A device for mechanical ventilation, consisting of a connecting piece , a rotary sleeve , a breathing tube and a patient interface, wherein the connecting piece is configured to be at least partially inserted into the rotary sleeve and locked with this, wherein the connecting piece and the rotary sleeve are configured to be arranged between the breathing tube and the patient interface, wherein the connecting piece has an external diameter (D3) which is smaller than an internal diameter (D4) of the rotary sleeve , and wherein the rotary sleeve has on its inner side locking elements which are configured to engage in locking elements which are formed on an outer wall of the connector , wherein the rotary sleeve is conical, which is why the external diameter (D5) of the rotary sleeve flares up to the end which is configured to face the connecting piece , wherein the rotary sleeve has an integral outer wall and symmetrical extensions of the integral outer wall .
A phenol compound represented by general formula (I), shown below, where, in general formula (I), R 1 and R 2 each indicate, independently of each other, a hydrogen atom or an alkyl group.
A device for suturing biological tissue, the device comprising: an elongate body having a proximal end and a distal end; at least one arm extendible from the elongate body , the at least one arm configured to move between a retracted position wherein the at least one arm is within the elongate body and a deployed position wherein the at least one arm extends away from the elongate body , the at least one arm configured to hold a first portion of a suture ; at least one needle moveable relative to the elongate body between a retracted position and a deployed position, wherein the at least one needle when moving from its retracted position to its deployed position is configured to pass through tissue and capture the suture first portion held by the at least one arm , and is further configured to move from the deployed position to the retracted position to bring the suture first portion through the tissue; a handle located at the proximal end of the elongate body , the handle having one or more actuators configured to cause movement of the at least one arm and the at least one needle ; and at least one suture spool configured to retain a second portion of the suture ; wherein, when the suture first portion is captured by the at least one needle and the at least one needle brings the suture first portion through the tissue, the at least one suture spool is configured such that the at least one suture unwinds from the at least one suture spool . characterized in that the at least one suture spool is mountable in fixed relationship to and located external to the elongate body and the handle . an elongate body having a proximal end and a distal end; at least one arm extendible from the elongate body , the at least one arm configured to move between a retracted position wherein the at least one arm is within the elongate body and a deployed position wherein the at least one arm extends away from the elongate body , the at least one arm configured to hold a first portion of a suture ; at least one needle moveable relative to the elongate body between a retracted position and a deployed position, wherein the at least one needle when moving from its retracted position to its deployed position is configured to pass through tissue and capture the suture first portion held by the at least one arm , and is further configured to move from the deployed position to the retracted position to bring the suture first portion through the tissue; a handle located at the proximal end of the elongate body , the handle having one or more actuators configured to cause movement of the at least one arm and the at least one needle ; and at least one suture spool configured to retain a second portion of the suture ; wherein, when the suture first portion is captured by the at least one needle and the at least one needle brings the suture first portion through the tissue, the at least one suture spool is configured such that the at least one suture unwinds from the at least one suture spool . characterized in that the at least one suture spool is mountable in fixed relationship to and located external to the elongate body and the handle .
A method for manufacturing a three-dimensional molded product, comprising obtaining a three-dimensional molded product in inkjet type three-dimensional molding by immersing a roughly molded product formed from a model material (A) forming a molded product and a support material (B) supporting the shape of the model material (A) during molding in a washing liquid (C), and peeling the support material (B) which has swelled from an interface with the model material (A), characterized in that the swelling ratio of the support material (B) is 10% or more, and the swelling ratio of the model material (A) is 1% or less when the roughly molded product is immersed in the washing liquid (C); and the support material (B) is a cured product of a photocurable ink (E) comprising: 0.5 to 5.0% by mass of a urethane acrylamide (b1) having a polyethylene glycol skeleton; 2.0 to 50.0% by mass of N-(2-hydroxyethyl) acrylamide (b2); 2.0 to 30.0% by mass of a cationic monomer (b3) represented by general formula ; 40.0 to 70.0% by mass of a compound (b4) having an alkylene glycol structure; and 0.1 to 5.0% by mass of a photopolymerization initiator (b5); [Chemical formula 1] CH 2 = CH-CO-Y-Z-N + (CH 3 ) 3 X - General formula In the formula, Y represents an oxygen atom or NH, Z represents an ethylene group or a propylene group, X- represents methylsulfonate or p-toluenesulfonate. 0.5 to 5.0% by mass of a urethane acrylamide (b1) having a polyethylene glycol skeleton; 2.0 to 50.0% by mass of N-(2-hydroxyethyl) acrylamide (b2); 2.0 to 30.0% by mass of a cationic monomer (b3) represented by general formula ; 40.0 to 70.0% by mass of a compound (b4) having an alkylene glycol structure; and 0.1 to 5.0% by mass of a photopolymerization initiator (b5); [Chemical formula 1] CH 2 = CH-CO-Y-Z-N + (CH 3 ) 3 X - General formula In the formula, Y represents an oxygen atom or NH, Z represents an ethylene group or a propylene group, X- represents methylsulfonate or p-toluenesulfonate.
A quantum computing method comprising: generating quantum processor control information for a group of devices housed in a quantum processor cell , each device in the group having a distinct operating frequency; generating a multiplexed control signal based on the quantum processor control information; communicating the multiplexed control signal from a first, higher temperature stage to a second, lower temperatures stage , wherein the second temperature stage comprises a low-noise, cryogenic environment; communicating the multiplexed control signal on a physical channel into an input signal processing system , the input signal processing system operating in the low-noise, cryogenic environment; separating device control signals from the multiplexed control signal by de-multiplexing the multiplexed control signal in the input signal processing system , wherein the multiplexed control signal is de-multiplexed by a de-multiplexer device operating in the low-noise, cryogenic environment, and the de-multiplexer device separates the device control signal from an input channel onto multiple output channels, the output channels comprising a distinct physical channel for each device in the group; and communicating the respective device control signals on the output channels into the quantum processor cell for the group of devices, the quantum processor cell operating in the low-noise, cryogenic environment. generating quantum processor control information for a group of devices housed in a quantum processor cell , each device in the group having a distinct operating frequency; generating a multiplexed control signal based on the quantum processor control information; communicating the multiplexed control signal from a first, higher temperature stage to a second, lower temperatures stage , wherein the second temperature stage comprises a low-noise, cryogenic environment; communicating the multiplexed control signal on a physical channel into an input signal processing system , the input signal processing system operating in the low-noise, cryogenic environment; separating device control signals from the multiplexed control signal by de-multiplexing the multiplexed control signal in the input signal processing system , wherein the multiplexed control signal is de-multiplexed by a de-multiplexer device operating in the low-noise, cryogenic environment, and the de-multiplexer device separates the device control signal from an input channel onto multiple output channels, the output channels comprising a distinct physical channel for each device in the group; and communicating the respective device control signals on the output channels into the quantum processor cell for the group of devices, the quantum processor cell operating in the low-noise, cryogenic environment.
Fluid composition in the form of an aqueous solution comprising potassium hydroxide (KOH) in an amount of from 0.01 to 15 wt. %, related to the total amount of the composition wherein water is the carrier and wherein the solution is alkaline having a pH value of 9.5 to 15 for the use in the dermal treatment of actinic keratosis wherein ibuprofen is not comprised in the composition.
An in vitro or ex vivo method for identifying apoptosis inhibitor of macrophage (AIM) polypeptides in a sample from a human, the method comprising: immunopurifying IgM immunoglobulins and AIM polypeptides bound to said IgM immunoglobulins from the sample, wherein said sample is a biological fluid, wherein said immunopurifying comprises using an anti-IgM antibody, wherein said anti-IgM antibody is an anti-human antibody, and wherein AIM polypeptides bound to IgM immunoglobulins are released from the IgM immunoglobulins; subjecting the immunopurified immunoglobulins and AIM polypeptides to a top-down mass spectrometry technique to obtain a mass spectrum of the sample; and identifying the presence of AIM polypeptides based on the multiply charged ion peaks in the spectrum corresponding to the AIM polypeptides. immunopurifying IgM immunoglobulins and AIM polypeptides bound to said IgM immunoglobulins from the sample, wherein said sample is a biological fluid, wherein said immunopurifying comprises using an anti-IgM antibody, wherein said anti-IgM antibody is an anti-human antibody, and wherein AIM polypeptides bound to IgM immunoglobulins are released from the IgM immunoglobulins; subjecting the immunopurified immunoglobulins and AIM polypeptides to a top-down mass spectrometry technique to obtain a mass spectrum of the sample; and identifying the presence of AIM polypeptides based on the multiply charged ion peaks in the spectrum corresponding to the AIM polypeptides.
A device for printing a closure device for containers which comprises a safety capsule , characterized in that said closure device comprises a first body and a second body each of which has a respective relative positioning element which are designed, at least in a step of use of said closure device , to be arranged and/or oriented with respect to each other in a predetermined position, said printing device comprising a supporting device for at least one of said bodies , a device configured to detect the position or orientation of the relative positioning element of the body supported by said support device , and a device configured for digital printing of at least one portion of the body supported by said supporting device in order to perform a printing operation in a predetermined position and/or with a predetermined orientation with respect to the position and/or orientation of the respective relative positioning element , said first body comprising an outer cap of said safety capsule which is provided with coupling means for coupling to the neck of a container , and said second body comprising an inner element which is designed to be arranged inside said outer cap and is adapted to be removably associated with an opening of said container , said bodies comprising at least one reference element , which is arranged or oriented in a predetermined manner with respect to the respective relative positioning elements , said at least one reference element being chosen from the group that comprises: - a three-dimensional portion of the respective body that can be detected by said detection device ; - a two-dimensional region of the respective body that can be detected by said detection device ; - a magnetic element which is embedded in or associated with the respective body that can be detected by said detection device ; - a metallic element which is embedded in or associated with the respective body that can be detected by said detection device ; - an element made of a material that is different from the one that constitutes the respective body , which is embedded in or associated with the respective body that can be detected by said detection device . - a three-dimensional portion of the respective body that can be detected by said detection device ; - a two-dimensional region of the respective body that can be detected by said detection device ; - a magnetic element which is embedded in or associated with the respective body that can be detected by said detection device ; - a metallic element which is embedded in or associated with the respective body that can be detected by said detection device ; - an element made of a material that is different from the one that constitutes the respective body , which is embedded in or associated with the respective body that can be detected by said detection device .
A control device comprising: an illuminating control unit configured to adjust a light amount of an illuminating device according to an inclination with respect to a photographing target of a body of a flight vehicle device that has an imaging device configured to photograph a photographing target and the illuminating device configured to illuminate the photographing target.